British pharmaceutical giant AstraZeneca on Friday announced plans to invest $2.5 billion in China, despite the detention ...

AstraZeneca has announced a $2.5 billion investment in a research and development hub in Beijing, underscoring its commitment ...

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to discover and develop next-generation multi-specific antibodies for ...

Massive rallies broke out in Seoul Saturday as supporters and opponents of South Korean President Yoon Suk Yeol took to the ...

British pharmaceutical giant AstraZeneca signed a landmark agreement on Friday to invest 2.5-billion U.S. dollars in Beijing over the next five years, signaling the multinational's confidence in the ...

British pharmaceutical giant AstraZeneca signed a landmark agreement on Friday to invest $2.5 billion in Beijing over the next five years, signaling the multinational's confidence in the world's ...

Israel on Saturday launched airstrikes against dozens of Hezbollah rocket launchers and a command center in response to a ...

The pharma is spending $2.5 billion on an R&D center in Beijing. Elsewhere, Adaptimmune warned it could run out of cash and Pfizer sold its remaining stake in Haleon.

British pharmaceutical giant AstraZeneca signed a landmark agreement on Friday to invest 2.5-billion U.S. dollars in Beijing over the next five ...

Here are some of the major companies whose stocks moved on the week's news. The CEO aimed to excite employees and investors about futuristic, if unproven, lines of business Tesla will pursue, ...

AstraZeneca said on Friday it will spend Ksh.323 billion on a research and development hub in Beijing, as the drugmaker ...

In a bold move to cement its foothold in China’s booming biopharmaceutical sector, AstraZeneca announced Friday a $2.5 billion investment in Beijing over the next five years. The pharmaceutical titan ...